参考文献/References:
[1] Roy MS, Klein R, O'Colmain BJ, et al. The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United States [J]. Arch Ophthalmol, 2004, 122(4):546-551. DOI:10.1001/archopht.122.4.546.
[2] Scanlon P, Aldington S, Stratton I. Epidemiological issues in diabetic retinopathy[J].Middle East Afr J Ophthalmol,2013,20(4):293-300. DOI:10.4103/0974-9233.120007.
[3] Lu J, Bi Y, Wang T, et al. The relationship between insulin-sensitive obesity and cardiovascular diseases in a Chinese population[J]. Int J Cardiol,2014,172(2):388-394. DOI:10.1016/j.ijcard.2014.01.073.
[4] Ning G, Bloomgarden Z. Diabetes and cancer:findings from the REACTION study[J].J Diabetes,2015,7(2):143-144. DOI:10.1111/1753-0407.12240.
[5] Janghorbani M, Jones RB, Murray KJ, et al. Incidence of and risk factors for diabetic retinopathy in diabetic clinic attenders[J]. Ophthalmic Epidemiol,2002, 8(5):309-325. DOI:10.1080/09286586.2001.11644259.
[6] Yau JWY, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy[J]. Diabetes Care,2012,35(3):556-564.DOI:10.2337/dc11-1909.
[7] Cai X, Chen Y, Yang W, et al. The association of smoking and risk of diabetic retinopathy in patients with type 1 and type 2 diabetes: a meta-analysis[J]. Endocrine,2018,62(2):299-306.DOI:10.1007/s12020-018-1697-y.
[8] Janghorbani M, Amini M, Ghanbari H, et al. Incidence of and risk factors for diabetic retinopathy in Isfahan, Iran[J].Ophthalmic Epidemiol, 2003, 10(2):81-95.DOI:10.1076/opep.10.2.81.13893.
[9] Rasoulinejad SA, Hajian K, Mehdipour E. Associated factors of diabetic retinopathy in patients that referred to teaching hospitals in Babol[J].Caspian J Intern Med, 2015, 6(4):224-228.
[10] Guillausseau PJ, Massin P, Charles MA, et al. Glycemic control and development of retinopathy in type 2 diabetes mellitus: a longitudinal study[J].Diabet Med,1998,15(2):151-155. DOI:10.1002/(SICI)1096-9136(199802)15:2<151:AID-DIA527>3.0.CO; 2-I.
[11] Chaturvedi N, Sjoelie AK, Porta M, et al. Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes[J]. Diabetes Care,2001,24(2):284. DOI:10.2337/diacare.24.2.284.
[12] Yan ZP, Ma JX. Risk factors for diabetic retinopathy in Northern Chinese patients with type 2 diabetes mellitus[J]. Int J Ophthalmol,2016, 9(8):1194-1199.DOI:10.18240/ijo.2016.08.17.
[13] Klein R, Knudtson MD, Lee KE, et al. The wisconsin epidemiologic study of diabetic retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes[J].Ophthalmology, 2008, 115(11):1859-1868.DOI:10.1016/j.ophtha.2008.08.023.
[14] Janghorbani M, Jones RB, Allison SP. Incidence of and risk factors for proliferative retinopathy and its association with blindness among diabetes clinic attenders[J]. Ophthalmic Epidemiol,2000,7(4):225-241.DOI:10.1076/opep.7.4.225.4171.
[15] Nittala M, Keane P, Zhang K, et al. Risk factors for proliferative diabetic retinopathy in a Latino American population[J]. Retina,2012,34(8):1594-1599.DOI:10.1097/IAE.0000000000000117.
[16] Stratton IM, Kohner EM, Aldington SJ, et al. UKPDS 50:risk factors for incidence and progression of retinopathy in type Ⅱ diabetes over 6 years from diagnosis[J]. Diabetologia,2001,44(2):156-163.DOI:10.1007/s001250051594.
[17] Lois N, Abdelkader E, Reglitz K, et al. Environmental tobacco smoke exposure and eye disease[J]. Br J Ophthalmol,2008,92(10):1304-1310.DOI:10.1136/bjo.2008.141168.
相似文献/References:
[1]苏月,王洁,于珮.血浆纤维蛋白原在糖尿病视网膜病变
患者中的水平及意义[J].国际内分泌代谢杂志,2016,36(01):1.[doi:10.3760/cma.j.issn.1673-4157.2016.01.001]
Su Yue,Wang Jie,Yu Pei..Level of plasma fibrinogen in patients with diabetic retinopathy and its significance[J].International Journal of Endocrinology and Metabolism,2016,36(04):1.[doi:10.3760/cma.j.issn.1673-4157.2016.01.001]
[2]殷俏,张云良,郭淑芹,等.视黄醇结合蛋白4、超敏C反应蛋白
与糖尿病视网膜病变的关系[J].国际内分泌代谢杂志,2016,36(03):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
Yin Qiao,Zhang Yunliang,Guo Shuqin,et al.Relationship of retinol binding protein 4 and high sensitive C-reactive protein with diabetic retinopathy[J].International Journal of Endocrinology and Metabolism,2016,36(04):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
[3]高璐,信中,袁明霞,等.代谢综合征与糖尿病及糖尿病前期人群
糖尿病视网膜病变的相关性分析[J].国际内分泌代谢杂志,2017,37(05):298.
Gao Lu*,Xin Zhong,Yuan Mingxia,et al.A study on correlation between metabolic syndrome and diabetic retinopathy in diabetic and pre-diabetic people[J].International Journal of Endocrinology and Metabolism,2017,37(04):298.
[4]刘晓妮 王颖 李桃桃 马小敏 梁彦.血管紧张素转换酶基因rs4353多态性
与糖尿病微血管病变的相关性研究[J].国际内分泌代谢杂志,2018,38(03):149.[doi:10.3760/cma.j.issn.1673-4157.2018.03.002]
Liu Xiaoni*,Wang Ying,Li Taotao,et al.Association between angiotensin converting enzyme gene rs4353 polymorphism and diabetic microangiopathy[J].International Journal of Endocrinology and Metabolism,2018,38(04):149.[doi:10.3760/cma.j.issn.1673-4157.2018.03.002]
[5]毕会利 张慧娟.信号素3家族与糖尿病及其微血管并发症[J].国际内分泌代谢杂志,2018,38(02):110.[doi:10.3760/cma.j.issn.1673-4157.2018.02.010]
Bi Huili,Zhang Huijuan..Class 3 semaphorins in diabetes mellitus and its microvascular complications[J].International Journal of Endocrinology and Metabolism,2018,38(04):110.[doi:10.3760/cma.j.issn.1673-4157.2018.02.010]
[6]张博 李凤君 左中夫.生长抑素对糖尿病大鼠视网膜病变的神经
保护作用及对GFAP、突触素表达的影响[J].国际内分泌代谢杂志,2018,38(06):370.[doi:10.3760/cma.j.issn.1673-4157.2018.06.003]
Zhang Bo*,Li Fengjun,Zuo Zhongfu.The neuroprotection of somatostatin and its effects on the expression of GFAP and synaptophysin in rats with diabetic retinopathy[J].International Journal of Endocrinology and Metabolism,2018,38(04):370.[doi:10.3760/cma.j.issn.1673-4157.2018.06.003]
[7]韩秀丹 朱凌燕 徐积兄.二甲双胍对糖尿病视网膜病变的作用及机制[J].国际内分泌代谢杂志,2019,39(01):53.[doi:10.3760/cma.j.issn.1673-4157.2019.01.013]
Han Xiudan,Zhu Lingyan,Xu Jixiong.Effects of metformin on diabetic retinopathy and its mechanism[J].International Journal of Endocrinology and Metabolism,2019,39(04):53.[doi:10.3760/cma.j.issn.1673-4157.2019.01.013]
[8]俞冰鸿 杨菊红 单春艳.阻塞性睡眠呼吸暂停低通气综合征与糖尿病
视网膜病变的关系[J].国际内分泌代谢杂志,2019,39(04):269.[doi:10.3760/cma.j.issn.1673-4157.2019.04.013]
Yu Binghong,Yang Juhong,Shan Chunyan.Relationship between obstructive sleep apnea syndrome and diabetic retinopathy[J].International Journal of Endocrinology and Metabolism,2019,39(04):269.[doi:10.3760/cma.j.issn.1673-4157.2019.04.013]
[9]黄庆先,胡文超,何兰杰.血清asprosin与糖尿病视网膜病变的
相关性研究[J].国际内分泌代谢杂志,2020,40(06):372.[doi:10.3760/cma.j.cn121383-20200311-03027]
Huang Qingxian,Hu Wenchao,He Lanjie.Association of serum asprosin concentrations with diabetic retinopathy[J].International Journal of Endocrinology and Metabolism,2020,40(04):372.[doi:10.3760/cma.j.cn121383-20200311-03027]
[10]董荣娜,李晶.人工智能在糖尿病视网膜病变诊断中应用的研究进展[J].国际内分泌代谢杂志,2020,40(06):412.[doi:10.3760/cma.j.cn121383-20200328-03075]
Dong Rongna,Li Jing.Advances in the application of artificial intelligence in the diagnosis of diabetic retinopathy[J].International Journal of Endocrinology and Metabolism,2020,40(04):412.[doi:10.3760/cma.j.cn121383-20200328-03075]